Myomo, Inc. (MYO)
USD 4.88
(2.95%)
USD 4.88
(2.95%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.8 Million USD | 28.83% |
| 2022 | 1.39 Million USD | 73.18% |
| 2021 | 808.3 Thousand USD | 14.31% |
| 2020 | 707.11 Thousand USD | 60.88% |
| 2019 | 439.53 Thousand USD | 71.59% |
| 2018 | 256.14 Thousand USD | 27.34% |
| 2017 | 201.15 Thousand USD | 144.02% |
| 2016 | 82.43 Thousand USD | -15.9% |
| 2015 | 98.02 Thousand USD | 70.17% |
| 2014 | 57.6 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.38 Million USD | 32.33% |
| 2024 Q2 | 2.6 Million USD | 8.99% |
| 2023 FY | 1.8 Million USD | 28.83% |
| 2023 Q4 | 1.8 Million USD | 21.47% |
| 2023 Q3 | 1.48 Million USD | 11.02% |
| 2023 Q2 | 1.33 Million USD | -14.56% |
| 2023 Q1 | 1.56 Million USD | 11.82% |
| 2022 Q3 | 1.48 Million USD | 17.61% |
| 2022 Q4 | 1.39 Million USD | -5.6% |
| 2022 FY | 1.39 Million USD | 73.18% |
| 2022 Q1 | 1.02 Million USD | 27.27% |
| 2022 Q2 | 1.26 Million USD | 22.57% |
| 2021 Q3 | 644.13 Thousand USD | -11.6% |
| 2021 Q2 | 728.63 Thousand USD | -8.21% |
| 2021 FY | 808.3 Thousand USD | 14.31% |
| 2021 Q1 | 793.79 Thousand USD | 12.26% |
| 2021 Q4 | 808.3 Thousand USD | 25.49% |
| 2020 Q3 | 759.8 Thousand USD | 11.92% |
| 2020 FY | 707.11 Thousand USD | 60.88% |
| 2020 Q4 | 707.11 Thousand USD | -6.93% |
| 2020 Q2 | 678.9 Thousand USD | 12.61% |
| 2020 Q1 | 602.88 Thousand USD | 37.16% |
| 2019 Q2 | 349.19 Thousand USD | 15.91% |
| 2019 Q3 | 454.37 Thousand USD | 30.12% |
| 2019 FY | 439.53 Thousand USD | 71.59% |
| 2019 Q4 | 439.53 Thousand USD | -3.27% |
| 2019 Q1 | 301.27 Thousand USD | 17.62% |
| 2018 Q4 | 256.14 Thousand USD | -6.06% |
| 2018 Q1 | 237.87 Thousand USD | 18.26% |
| 2018 FY | 256.14 Thousand USD | 27.34% |
| 2018 Q2 | 247.62 Thousand USD | 4.1% |
| 2018 Q3 | 272.66 Thousand USD | 10.11% |
| 2017 Q3 | 123.35 Thousand USD | 0.26% |
| 2017 Q2 | 123.02 Thousand USD | 26.53% |
| 2017 FY | 201.15 Thousand USD | 144.02% |
| 2017 Q1 | 97.23 Thousand USD | 17.95% |
| 2017 Q4 | 201.15 Thousand USD | 63.08% |
| 2016 Q2 | 90.47 Thousand USD | 0.0% |
| 2016 FY | 82.43 Thousand USD | -15.9% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q4 | 82.43 Thousand USD | 0.0% |
| 2015 FY | 98.02 Thousand USD | 70.17% |
| 2015 Q4 | 98.02 Thousand USD | 0.0% |
| 2015 Q3 | 98.02 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | 57.6 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 99.973% |
| Allurion Technologies Inc. | 6.17 Million USD | 70.774% |
| Artivion, Inc. | 81.97 Million USD | 97.8% |
| Avanos Medical, Inc. | 163.2 Million USD | 98.895% |
| Butterfly Network, Inc. | 75.83 Million USD | 97.622% |
| Butterfly Network, Inc. | 75.83 Million USD | 97.622% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 99.769% |
| Boston Scientific Corporation | 2.48 Billion USD | 99.927% |
| CONMED Corporation | 318.32 Million USD | 99.433% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 99.846% |
| Paragon 28, Inc. | 98.06 Million USD | 98.161% |
| Glaukos Corporation | 41.98 Million USD | 95.705% |
| Globus Medical, Inc. | 848.13 Million USD | 99.787% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | 94.678% |
| Integer Holdings Corporation | 239.71 Million USD | 99.248% |
| Medtronic plc | 5.21 Billion USD | 99.965% |
| Nevro Corp. | 118.67 Million USD | 98.48% |
| Owlet, Inc. | 6.49 Million USD | 72.224% |
| Penumbra, Inc. | 388.02 Million USD | 99.535% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.925% |
| STERIS plc | 674.53 Million USD | 99.733% |
| Stryker Corporation | 4.84 Billion USD | 99.963% |
| Vapotherm, Inc. | 22.96 Million USD | 92.148% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 99.924% |